Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
11,879
datasets available to search
ShareScore release 0.9.0
Dataset results
11,879 results for “participation”
A Study in Moderate to Severe Rheumatoid Arthritis Participants
ClinicalTrials.gov study NCT01721057. IPD Sharing: YES. Countries: 23. Publications: 13.
A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors
ClinicalTrials.gov study NCT03708328. IPD Sharing: NO. Countries: 6. Publications: 0.
Efficacy and Safety of Suvorexant (MK-4305) for Reducing Incidence of Delirium in Japanese Participants at High Risk of Delirium (MK-4305-085)
ClinicalTrials.gov study NCT04571944. IPD Sharing: YES. Countries: 1. Publications: 1.
Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)
ClinicalTrials.gov study NCT01894516. IPD Sharing: Not stated. Countries: 19. Publications: 4.
Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002)
ClinicalTrials.gov study NCT02609984. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to Methotrexate
ClinicalTrials.gov study NCT02960438. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF
ClinicalTrials.gov study NCT02163759. IPD Sharing: Not stated. Countries: 14. Publications: 2.
Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency
ClinicalTrials.gov study NCT00297167. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)
ClinicalTrials.gov study NCT04498247. IPD Sharing: YES. Countries: 3. Publications: 1.
Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-
ClinicalTrials.gov study NCT03933449. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine
ClinicalTrials.gov study NCT04179474. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera
ClinicalTrials.gov study NCT03287245. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
ClinicalTrials.gov study NCT05564039. IPD Sharing: YES. Countries: 5. Publications: 1.
CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)
ClinicalTrials.gov study NCT03163667. IPD Sharing: NO. Countries: 1. Publications: 2.
Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy
ClinicalTrials.gov study NCT04319198. IPD Sharing: NO. Countries: 3. Publications: 1.
A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT04760314. IPD Sharing: YES. Countries: 1. Publications: 1.
A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod
ClinicalTrials.gov study NCT02215616. IPD Sharing: Not stated. Countries: 10. Publications: 2.
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
ClinicalTrials.gov study NCT02118584. IPD Sharing: Not stated. Countries: 42. Publications: 1.
Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression
ClinicalTrials.gov study NCT01396447. IPD Sharing: Not stated. Countries: 6. Publications: 7.
A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT03512756. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.